Calypte Biomedical Corp. Gets FDA Approval for Its HIV-1 Urine EIA Screening Test
Posted on: Friday, 9 September 2005, 21:00 CDT
Calypte Biomedical Corp. announced that the U.S. Food and Drug Administration approved the company's Rockville facility as the manufacturing site for its HIV-1 Urine EIA screening test
. In 1996, Calypte's test became the first, and remains the only, FDA-approved screening test for HIV-1 antibody capable of using urine samples.Source: The Daily Record (Baltimore)
Related Articles
- Cholesterol Test at 50 Most Efficient Heart Tracker
- Columbia Probe Finalizing Wing Tests
- Canseco Arrested After Positive Drug Test
- Canada to Slaughter, Test More Cattle
- DNA Test May Detect Prostate Cancer Early
- Disney to Test Video on Demand Service
- Cervical Cancer Test May Be Widely Used
- Blood Test May Measure Colon Cancer Risk
- Blood Marker Eyed in Colon Cancer Test
- FDA Approves New Heart Attack Test
Rating: 3.3 / 5 (7 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds